Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Clinica Baviera (CBAV) Price & Analysis

CBAV Stock Chart & Stats

€53.20-€0.60(-1.12%)
At close: 4:00 PM EDT
EUR 52.5EUR 55EUR 57.5EUR 603 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 53.00 - EUR 54.00
52-Week Range
EUR 40.10 - EUR 62.00
Previous Close
EUR 53.80
Volume
38
Average Volume (3M)
2,001
Market Cap
EUR 867.34M
Enterprise Value
EUR 882.45M
Total Cash (Recent Filing)
EUR 51.59M
Total Debt (Recent Filing)
EUR 9.90M
Price to Earnings (P/E)
19.0
Beta
0.51
Next Earnings
Nov 05, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
2.95%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

The sustained increase in revenue indicates expanding demand for Clinica Baviera’s ophthalmology services across its clinic network. Continued top-line growth supports operating leverage, provides resources for clinic investment, and strengthens the company’s ability to compound earnings over the next several quarters.

Strong Profitability

Consistently strong net margins show that the company converts clinical service revenue into meaningful earnings across reporting periods. This profitability provides resilience, supports reinvestment in its operating network, and gives management flexibility to pursue growth without relying solely on external financing.

Healthy Cash Generation

Operating cash flow consistently exceeding net income supports the quality of reported earnings and indicates effective cash realization from operations. Positive and improving free cash flow also strengthens the company’s capacity to fund investment, reduce debt, and support future shareholder returns.

Bears Say

Margin Volatility

Recent changes in gross and operating margins introduce uncertainty around how durable the company’s current profitability is. If the movement reflects cost or pricing pressure rather than temporary mix effects, continued margin volatility could limit earnings growth even while revenue remains positive.

Moderate Free-Cash-Flow Conversion

Although free cash flow remains positive, only moderate conversion from net income means reported profits do not consistently become available cash at the same rate. Ongoing reinvestment needs or working-capital movements could constrain debt reduction, capital returns, and internally funded expansion.

Deleveraging Durability

The recent balance-sheet improvement is a clear strength, but historically elevated leverage means its durability still matters to the investment case. If the latest debt reduction reflects timing rather than a structural change, financial flexibility could prove less durable during expansion or weaker operating conditions.

Clinica Baviera News

CBAV FAQ

What was Clinica Baviera’s price range in the past 12 months?
Clinica Baviera lowest stock price was €40.10 and its highest was €62.00 in the past 12 months.
What is Clinica Baviera’s market cap?
Clinica Baviera’s market cap is €867.34M.
When is Clinica Baviera’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Clinica Baviera’s earnings last quarter?
Clinica Baviera released its earnings results on Jul 29, 2026. The company reported €0.747 earnings per share for the quarter.
Is Clinica Baviera overvalued?
According to Wall Street analysts Clinica Baviera’s price is currently Undervalued.
Does Clinica Baviera pay dividends?
Clinica Baviera pays a Annually dividend of €1.568 which represents an annual dividend yield of 2.95%. See more information on Clinica Baviera dividends here
What is Clinica Baviera’s EPS estimate?
Clinica Baviera’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinica Baviera have?
Clinica Baviera has 16,307,580 shares outstanding.
What happened to Clinica Baviera’s price movement after its last earnings report?
Clinica Baviera reported an EPS of €0.747 in its last earnings report. Following the earnings report the stock price went down -1.024%.
Which hedge fund is a major shareholder of Clinica Baviera?
Currently, no hedge funds are holding shares in ES:CBAV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology